YH22189 FDC

YH22189 fixed-dose combination · Yuhan Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YH22189 FDC, covering 2017-02-01 to 2017-02-01. Get the full timeline:

Most recent: Clinical Trial Update: PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and Rosuvastatin [Phase 1]